FDA Approves Two More COVID-19 Vaccines For Use In Ghana
Updated: Jul 30, 2021
The Food and Drugs Authority (FDA) has revealed that it has approved two (2) more covid-19 vaccines for importation, distribution and in use in Ghana.
According to a communique signed by its Chief Executive Officer (CEO), Delese Darko, the two new vaccines are Moderna (Spikevax) and Pfizer BioNtech (Comirnaty).
The statement further said "The two new vaccines are Moderna (Spikevax) and Pfizer BioNtech (Comirnaty) bringing the total number of approved covid-19 vaccines for use in Ghana to five (5) and are as follows: Sputnik V, Covishield, Covid-19 Vaccine Jason, Moderna (Spikevax) and Pfizer-BioNtech (Comirnaty).
The release also hinted that the FDA continues to use the Emergency Use Authorization (EUA) pathway, which is the accepted procedure for all national regulatory authorities globally, in order to ensure timely access to quality and safe medical products including vaccines during the pandemic.
The Authority says it is assuring the public that all the approved covid-19 vaccines have been subjected to rigorous safety parameters and therefore the public are to receive the vaccines without any reservations.
Below is a copy of the release:
Story by: Joshua Kwabena Smith